Fagan Associates’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,495
Closed -$444K 113
2019
Q4
$444K Hold
10,495
0.14% 91
2019
Q3
$439K Buy
10,495
+3,855
+58% +$150K 0.17% 86
2019
Q2
$244K Buy
+6,640
New +$242K 0.1% 105
2015
Q2
Sell
-14,189
Closed -$575K 98
2015
Q1
$575K Buy
14,189
+1,714
+14% +$71K 0.43% 64
2014
Q4
$487K Buy
12,475
+3,234
+35% +$123K 0.39% 63
2014
Q3
$316K Sell
9,241
-62
-0.7% -$2.28K 0.26% 75
2014
Q2
$343K Buy
9,303
+430
+5% +$15.3K 0.29% 71
2014
Q1
$298K Buy
+8,873
New +$283K 0.26% 75

Other funds holding OHI

Fagan Associates's OHI Position: Q1 2020 in Review

Fagan Associates sold out of Omega Healthcare (OHI) in Q1 2020, closing a stake of 10,495 shares — an estimated $444K sold.

Fagan Associates first reported a position in OHI in Q1 2014 and held it in 8 quarters. The position peaked at $575K in Q1 2015. 469 funds tracked by Wall St. Rank hold OHI as of Q1 2020.

  • Fagan Associates reported no remaining Omega Healthcare position as of Q1 2020 after selling out during the quarter.
  • Fagan Associates sold 10,495 Omega Healthcare shares in Q1 2020, an estimated $444K.
  • Fagan Associates first reported a position in Omega Healthcare in Q1 2014 and held it in 8 quarters.
  • Fagan Associates's Omega Healthcare position peaked at $575K in Q1 2015.
  • 469 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2020.

Based on Fagan Associates's 13F filing for Q1 2020, filed 5 May 2020.